Stealthy AtheroMed Raises $6M for Peripheral Atherectomy Device
AtheroMed, which is developing an atherectomy device to treat peripheral artery disease, reports a $6 million funding round.
AtheroMed said it's raised a $6 million equity round, taking its total funding raise since 2009 to $20 million, according to regulatory filings.
The Menlo Park, Calif.-based medical device company is developing an atherectomy device for treating peripheral artery disease, according to its website.
AtheroMed is still flying under the radar, to judge by the 1-page website, which provides only an email link to contact the company.